Challenges to sovereign ambitions: forces of convergence and divergence within the global pharmaceutical sector and the UK's withdrawal from the European Union

scientific article published on 25 June 2020

Challenges to sovereign ambitions: forces of convergence and divergence within the global pharmaceutical sector and the UK's withdrawal from the European Union is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S174413312000016X
P698PubMed publication ID32583755

P50authorJohn S F WrightQ96690173
P2093author name stringDimitrios Doukas
P2860cites work'Linkage' pharmaceutical evergreening in Canada and AustraliaQ21232002
Canada's patented medicine notice of compliance regulations: balancing the scales or tipping them?Q33854927
Improving regulatory capacity to manage risks associated with trade agreementsQ35223583
The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and AustraliaQ38832033
Regulating the drugs industry transparentlyQ42955898
Brewer's yeast as a cause of infectionQ44372924
Globalization and the pharmaceutical industry revisitedQ47419256
'A pill for every ill': explaining the expansion in medicine use.Q53481876
Impact of the Australia–US Free Trade Agreement on Australian medicines regulation and pricesQ56115857
How the Australia-US free trade agreement compromised the pharmaceutical benefits schemeQ57742509
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United StatesQ57791553
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impactsQ91493643
P304page(s)1-17
P577publication date2020-06-25
P1433published inHealth Economics, Policy and LawQ15766164
P1476titleChallenges to sovereign ambitions: forces of convergence and divergence within the global pharmaceutical sector and the UK's withdrawal from the European Union

Search more.